Therefore, based on these results, we conclude that among the T cell subsets of PBMCs obtained from GPA/MPA patients, rapamycin may significantly suppress the polarisation of CD4+ T cells towards CD4+IFN-γ+ T (TH1) cells with high vasculitic activity. The gene discussed is CD4; the disease is granulomatosis with polyangiitis.